Amundi Boosts Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Amundi lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,070,086 shares of the medical equipment provider’s stock after buying an additional 563 shares during the period. Intuitive Surgical makes up 0.6% of Amundi’s holdings, making the stock its 25th biggest position. Amundi owned 0.86% of Intuitive Surgical worth $1,667,374,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. M.E. Allison & CO. Inc. purchased a new position in Intuitive Surgical during the fourth quarter worth about $449,000. Seilern Investment Management Ltd purchased a new position in Intuitive Surgical during the fourth quarter worth about $82,517,000. Sycomore Asset Management raised its stake in Intuitive Surgical by 27.4% during the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after purchasing an additional 4,079 shares during the period. Exome Asset Management LLC raised its stake in Intuitive Surgical by 16.8% during the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after purchasing an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. raised its stake in Intuitive Surgical by 5.6% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after purchasing an additional 525 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. lifted their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Truist Financial lifted their price target on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Raymond James lifted their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Barclays lifted their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Finally, Evercore ISI lifted their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have given a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Stock Down 3.8 %

NASDAQ ISRG opened at $518.26 on Friday. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The stock has a market capitalization of $184.59 billion, a PE ratio of 80.85, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The firm has a 50 day moving average of $571.36 and a two-hundred day moving average of $531.20.

Insiders Place Their Bets

In other news, CFO Jamie Samath sold 270 shares of the business’s stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total transaction of $145,840.50. Following the completion of the sale, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,730,093.55. The trade was a 2.99 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Mark Brosius sold 489 shares of the business’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $533.18, for a total transaction of $260,725.02. Following the sale, the senior vice president now owns 2,091 shares of the company’s stock, valued at $1,114,879.38. This represents a 18.95 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 13,579 shares of company stock worth $7,756,844 in the last 90 days. Corporate insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.